Which host, microbial, and treatment factors explain persistent or recurrent ulcer disease after standard H. pylori eradication?
American College of Gastroenterology guideline on H. pylori treatment · Cathedral editorial seed · Open
Discover
Research stories, evidence shifts, forgotten threads, and open questions—each connected to a source record.
Visual stories selected from the current Cathedral index.
American College of Gastroenterology guideline on H. pylori treatment · Cathedral editorial seed · Open
USGS, Understanding plate motions · Cathedral editorial seed · Open
NCI RAS Initiative · Cathedral editorial seed · Open
Sub-optimal dosing and incomplete treatment courses may drive resistance. It remains open whether dispensing patterns can predict future hotspots before clinical failure is observed.
Evidence of Artemisinin-Resistant Malaria in Africa · Cathedral concept synthesis · Open
Artemisinin requires activation by heme to become toxic to the parasite. K13 mutations appear to reduce activation, but the complete pathway connecting K13 function to heme release remains disputed.
Evidence of Artemisinin-Resistant Malaria in Africa · Cathedral concept synthesis · Open
The C580Y mutation accounts for the majority of validated artemisinin resistance cases globally. Other K13 mutations also confer resistance but are less prevalent; the structural and biochemical reason C580Y is so successful remains unresolved.
Questions preserved with a reason they remain open and evidence that could resolve them.
FOXP3 and regulatory T cell biology · Cathedral editorial seed · Open
Evidence of Artemisinin-Resistant Malaria in Africa · Cathedral concept synthesis · Open
If K13 mutations carry high fitness cost, resistance may recede without sustained drug pressure. If low cost, it may persist; current data is contradictory across studies.
Evidence of Artemisinin-Resistant Malaria in Africa · Cathedral concept synthesis · Open
USGS, Understanding plate motions · Cathedral editorial seed · Open
Cathedral editorial seed